DocSym
β
Searchsearch
Search
(P59.2) Neonatal jaundice from other and unspecified hepatocellular damage
More details coming soon
5 904 402 in individuals diagnosis neonatal jaundice from other and unspecified hepatocellular damage confirmed
2 325 deaths with diagnosis neonatal jaundice from other and unspecified hepatocellular damage
Diagnosis neonatal jaundice from other and unspecified hepatocellular damage is diagnosed Men are 11.99% more likely than Women
3 306 204
Men receive the diagnosis neonatal jaundice from other and unspecified hepatocellular damage
321 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
2 598 198
Women receive the diagnosis neonatal jaundice from other and unspecified hepatocellular damage
2 004 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease neonatal jaundice from other and unspecified hepatocellular damage - Men and Women aged 0
In Men diagnosis is most often set at age 0-5, 15-34
Less common in men the disease occurs at Age 5-14, 35-95+Less common in women the disease occurs at Age 5-9, 45-95+
In Women diagnosis is most often set at age 0-5, 10-44
Disease Features neonatal jaundice from other and unspecified hepatocellular damage
Absence or low individual and public risk
Neonatal jaundice from other and unspecified hepatocellular damage - what does this mean
Neonatal jaundice from other and unspecified hepatocellular damage occurs when there is damage to the liver cells of a newborn baby, resulting in an accumulation of bilirubin in the blood. this can be caused by a variety of factors, including infection, birth trauma, or an inherited metabolic disorder.
What happens during the disease - neonatal jaundice from other and unspecified hepatocellular damage
Neonatal jaundice is caused by an increased level of bilirubin in the blood due to other and unspecified hepatocellular damage. the liver is responsible for breaking down red blood cells and producing bile, a yellow-green fluid that helps to carry away waste products. when the liver is damaged, it cannot process the bilirubin produced from the breakdown of red blood cells, causing an accumulation of the substance in the bloodstream. this results in jaundice, a yellowing of the skin and eyes, which is characteristic of neonatal jaundice.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Liver function tests
- Ultrasound of the abdomen
- Bilirubin levels
- CT scan of the abdomen
- MRI of the abdomen
Treatment and Medical Assistance
Main Goal: Treat Neonatal Jaundice from other and unspecified hepatocellular damage.
- Administer phototherapy to reduce the levels of bilirubin in the blood
- Administer medications to reduce bilirubin levels
- Perform exchange transfusions to reduce the levels of bilirubin in the blood
- Monitor the levels of bilirubin in the blood
- Provide supportive care to the patient
- Treat any underlying conditions that may be causing the jaundice
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Neonatal jaundice from other and unspecified hepatocellular damage - Prevention
To prevent neonatal jaundice from other and unspecified hepatocellular damage, it is important to ensure that pregnant women receive the necessary prenatal care and that newborns are monitored for any signs or symptoms of jaundice. additionally, it is important to ensure that mothers are up to date on their vaccinations, as this can help to reduce the risk of jaundice in newborns. finally, it is important to ensure that newborns receive the necessary treatments, such as phototherapy, if they do develop jaundice.